Skip to main content
NEXTURNBIOSCIENCE Co., LTD logo

NEXTURNBIOSCIENCE Co., LTD — Investor Relations & Filings

Ticker · 089140 ISIN · KR7089140008 KO Professional, scientific and technical activities
Open in API
Filings indexed 486 across all filing types
Latest filing 2023-03-27 Regulatory Filings
Country KR South Korea
Listing KO 089140

About NEXTURNBIOSCIENCE Co., LTD

http://www.nexturn.co.kr

NEXTURNBIOSCIENCE Co., LTD. is a specialized manufacturer of Computer Numerical Control (CNC) automatic lathes, with a focus on Swiss-type models. The company develops and produces a range of machines, including both guide bush and non-guide bush types, utilizing proprietary technology. In addition to its core machinery business, NEXTURNBIOSCIENCE leverages its expertise in ultra-precision manufacturing to produce essential functional components. These high-quality parts serve critical applications across diverse sectors, including information technology (IT), construction equipment, and the medical industry, reflecting the company's expanding business scope.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) filed by Nexturn Bio. It details the contract value, counterparty, duration, and payment terms. Since this is a specific regulatory disclosure of a material business event that does not fit into categories like financial reports, board changes, or shareholder meetings, it falls under the general regulatory filing category.
2023-03-27 Korean
[기재정정]기타경영사항(자율공시)(제1,2,3,4회차 무기명식 무보증 사모 전환사채 만기전 취득 후 재매각의 건)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (Nexturn Bio) regarding the 'resale of convertible bonds' after they were previously acquired before maturity. This type of transaction relates to the company's capital structure and financing activities. Since it details the terms, counterparties, and financial impact of a capital-related transaction (convertible bond resale), it falls under the 'Capital/Financing Update' category.
2023-03-24 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Nexturn Bioscience, covering the fiscal year 2022 (Jan 1, 2022 to Dec 31, 2022). It contains comprehensive company information, financial data, business operations, and management details, which is the standard format for an Annual Report (10-K equivalent) in the South Korean regulatory framework. FY 2022
2023-03-21 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion, key financial data (assets, liabilities, equity, profit/loss), and auditor information for the fiscal year. While it contains financial data, it is a standardized regulatory disclosure form rather than the full annual report (10-K) or a standalone audit report (AR). In the context of Korean regulatory filings (DART/KIND), this specific disclosure format is categorized as a regulatory filing announcement. FY 2022
2023-03-20 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Nexturn Bio) regarding the adjustment of the conversion price of convertible bonds due to a decline in stock price. This type of disclosure is a standard capital structure update related to financing instruments. In the provided taxonomy, 'CAP' (Capital/Financing Update) is the most appropriate category for adjustments to convertible securities, as it directly impacts the company's capital structure and potential share dilution.
2023-03-20 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Nexturn Bio) regarding the adjustment of the conversion price of convertible bonds. This type of filing, which details changes to capital structure instruments like convertible debt, falls under the 'Capital/Financing Update' category. It is not a report publication announcement, but rather the primary disclosure of the financial event itself.
2023-03-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.